Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder

MG Miglis, CH Adler, E Antelmi, D Arnaldi… - The Lancet …, 2021 - thelancet.com
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving …

Idiopathic REM sleep behaviour disorder and neurodegeneration—an update

B Högl, A Stefani, A Videnovic - Nature Reviews Neurology, 2018 - nature.com
So-called idiopathic rapid eye movement (REM) sleep behaviour disorder (RBD), formerly
seen as a rare parasomnia, is now recognized as the prodromal stage of an α …

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

RB Postuma, A Iranzo, M Hu, B Högl, BF Boeve… - Brain, 2019 - academic.oup.com
Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson's
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

I Poggiolini, V Gupta, M Lawton, S Lee, A El-Turabi… - Brain, 2022 - academic.oup.com
Several studies have confirmed the α-synuclein real-time quaking-induced conversion (RT-
QuIC) assay to have high sensitivity and specificity for Parkinson's disease. However …

[HTML][HTML] Clinical and imaging evidence of brain-first and body-first Parkinson's disease

J Horsager, K Knudsen, M Sommerauer - Neurobiology of disease, 2022 - Elsevier
Braak's hypothesis has been extremely influential over the last two decades. However,
neuropathological and clinical evidence suggest that the model does not conform to all …

Quality of life in Parkinson's disease: A systematic review and meta‐analysis of comparative studies

N Zhao, Y Yang, L Zhang, Q Zhang… - CNS neuroscience & …, 2021 - Wiley Online Library
Background Studies regarding the impact of Parkinson's disease (PD) on quality of life
(QOL) have reported conflicting results, and the underlying QOL domains require further …

The α-synuclein origin and connectome model (SOC Model) of Parkinson's disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline

P Borghammer - Journal of Parkinson's disease, 2021 - content.iospress.com
A new model of Parkinson's disease (PD) pathogenesis is proposed, the α-Synuclein Origin
site and Connectome (SOC) model, incorporating two aspects of α-synuclein pathobiology …

GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches

GM Riboldi, AB Di Fonzo - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is the second most common degenerative disorder. Although the
disease was described more than 200 years ago, its pathogenetic mechanisms have not yet …

International consensus statement on allergy and rhinology: olfaction

ZM Patel, EH Holbrook, JH Turner… - International forum of …, 2022 - Wiley Online Library
Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies

A Galbiati, L Verga, E Giora, M Zucconi… - Sleep medicine …, 2019 - Elsevier
Several studies report an association between REM Sleep Behavior Disorder (RBD) and
neurodegenerative diseases, in particular synucleinopathies. Interestingly, the onset of RBD …